We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

100 hedge funds and large institutions have $102M invested in VivoSim Labs in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% more ownership

Funds ownership: 0% → 0.09% (+0.09%)

3% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 29

13% less funds holding

Funds holding: 115 → 100 (-15)

23% less capital invested

Capital invested by funds: $133M → $102M (-$30.6M)

23% less call options, than puts

Call options by funds: $6.96M | Put options by funds: $9.05M

56% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 27

Holders
100
Holders Change
-15
Holders Change %
-13.04%
% of All Funds
2.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
28
Reduced
29
Closed
27
Calls
$6.96M
Puts
$9.05M
Net Calls
-$2.09M
Net Calls Change
+$204K

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$4.13M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.93M
3
State Street
State Street
Massachusetts
+$1.81M
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$663K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$299K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$2.94M
2
U
UBS
Switzerland
-$2.15M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$621K
4
BL
Bolton LP
Connecticut
-$616K
5
VKH
Virtu KCG Holdings
New York
-$522K
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$522K – – –
Wells Fargo
27
Wells Fargo
California
$520K +$14.5K +8 +2%
AQR Capital Management
28
AQR Capital Management
Connecticut
$511K – – –
CS
29
Credit Suisse
Switzerland
$426K -$174K -96 -26%
Millennium Management
30
Millennium Management
New York
$423K -$14.5K -8 -3%
BCM
31
Beck Capital Management
Texas
$392K -$203K -112 -29%
MLICM
32
Metropolitan Life Insurance Company (MetLife)
New York
$379K – – –
AIG
33
American International Group
New York
$361K -$79.8K -44 -16%
Deutsche Bank
34
Deutsche Bank
Germany
$347K +$50.8K +28 +14%
ABI
35
Adamant Biomedical Investments
Switzerland
$319K +$377K +208 New
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$313K +$7.25K +4 +2%
VKH
37
Virtu KCG Holdings
New York
$309K -$522K -288 -59%
NFA
38
Nationwide Fund Advisors
Ohio
$309K +$5.44K +3 +2%
WSCM
39
Wellington Shields Capital Management
New York
$283K -$18.1K -10 -5%
JMPWA
40
JP Morgan Private Wealth Advisors
California
$248K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$246K +$67.1K +37 +30%
VOYA Investment Management
42
VOYA Investment Management
Georgia
$233K – – –
UBS AM
43
UBS AM
Illinois
$229K – – –
BA
44
BlackRock Advisors
Delaware
$226K +$67.1K +37 +33%
RJA
45
Raymond James & Associates
Florida
$213K -$97.9K -54 -28%
ARTA
46
A.R.T. Advisors
New York
$213K +$252K +139 New
Commonwealth Equity Services
47
Commonwealth Equity Services
Massachusetts
$207K – – –
CA
48
Cetera Advisors
Colorado
$207K +$23.6K +13 +11%
MSU
49
Mizuho Securities USA
New York
$197K +$234K +129 New
Tudor Investment Corp
50
Tudor Investment Corp
Connecticut
$194K +$230K +127 New
1
2
3 4 5

VIVS Hedge Fund Activity: Q3 2014 in Review

100 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q3 2014, worth a combined $102M — down 23% from $133M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of VIVS and 12 opened new positions — a net loss of 15 holders — while 29 trimmed existing stakes and 28 added.

The largest buyer was Northern Trust, adding an estimated $4.13M. The largest seller was Goldman Sachs, cutting an estimated $2.94M.

  • 100 institutional investors held VivoSim Labs (VIVS) as of Q3 2014, down from 115 in Q2 2014.
  • Funds reported $102M of VivoSim Labs stock for Q3 2014, down 23% quarter-over-quarter.
  • 12 funds opened new VivoSim Labs positions in Q3 2014 and 27 closed out, a net change of -15 holders.
  • The largest VivoSim Labs buyer in Q3 2014 was Northern Trust, an estimated $4.13M added.
  • The largest VivoSim Labs seller in Q3 2014 was Goldman Sachs, an estimated $2.94M sold.

Based on aggregated 13F filings for Q3 2014.